• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体部塑形对容积调强弧形治疗技术所输送剂量分布的影响。

The effect of body contouring on the dose distribution delivered with volumetric-modulated arc therapy technique.

作者信息

Lee Jaegi, Park Jong Min, Wu Hong-Gyun, Kim Jin Ho, Ye Sung-Joon

机构信息

Seoul National University Graduate School of Convergence Science and Technology and Seoul National University Hospital.

出版信息

J Appl Clin Med Phys. 2015 Nov 8;16(6):365-375. doi: 10.1120/jacmp.v16i6.5810.

DOI:10.1120/jacmp.v16i6.5810
PMID:26699591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5691003/
Abstract

The purpose of the study was to investigate the dosimetric effect defining the body structure with various Hounsfield unit (HU) threshold values on the dose distributions of volumetric-modulated arc therapy (VMAT) plans. Twenty patients with prostate cancer and twenty patients with head and neck (H&N) cancer were retrospectively selected. For each patient, the body structure was redefined with HU threshold values of -180 (Body180), -350 (Body350), -700 (Body700), and -980 (Body980). For each patient, dose-volumetric parameters with those body structures were calculated using identical VMAT plans. The differences in dose-volumetric parameters due to the varied HU threshold values were calculated. For the prostate boost target volume, the maximum dose, mean dose, D95%, and D5% with Body180 were higher than those with Body980 by approximately 0.7% (p < 0.001). For H&N target volumes, the changes in D95% of the targets receiving 67.5 Gy, 54 Gy, and 48 Gy between Body180 and Body980 were -1.2%, -0.9%, and -1.2%, respectively (p < 0.001). The differences were larger for H&N VMAT plans than for prostate VMAT plans due to the inclusion of an immobilization device in the irradiated region in H&N cases. To apply all attenuating materials to dose calculation, the body structure would be defined with -980 HU. Otherwise, systematic error of about 1%, resulting in underdosage of the target volume, can occur.

摘要

本研究的目的是探讨使用不同的亨氏单位(HU)阈值定义身体结构对容积调强弧形放疗(VMAT)计划剂量分布的剂量学影响。回顾性选取了20例前列腺癌患者和20例头颈部(H&N)癌患者。对于每位患者,分别使用-180(Body180)、-350(Body350)、-700(Body700)和-980(Body980)的HU阈值重新定义身体结构。对于每位患者,使用相同的VMAT计划计算这些身体结构的剂量-体积参数。计算由于HU阈值变化导致的剂量-体积参数差异。对于前列腺追加剂量靶区,Body180的最大剂量、平均剂量、D95%和D5%比Body980高约0.7%(p<0.001)。对于H&N靶区,在Body180和Body980之间,接受67.5 Gy、54 Gy和48 Gy的靶区D95%的变化分别为-1.2%、-0.9%和-1.2%(p<0.001)。由于H&N病例的照射区域包含固定装置,H&N的VMAT计划差异比前列腺VMAT计划更大。为了将所有衰减材料应用于剂量计算,身体结构应定义为-980 HU。否则,可能会出现约1%的系统误差,导致靶区剂量不足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/6a02e3f655b7/ACM2-16-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/863aea201b20/ACM2-16-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/3b27f25c0667/ACM2-16-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/6a02e3f655b7/ACM2-16-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/863aea201b20/ACM2-16-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/3b27f25c0667/ACM2-16-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/879e/5691003/6a02e3f655b7/ACM2-16-365-g003.jpg

相似文献

1
The effect of body contouring on the dose distribution delivered with volumetric-modulated arc therapy technique.体部塑形对容积调强弧形治疗技术所输送剂量分布的影响。
J Appl Clin Med Phys. 2015 Nov 8;16(6):365-375. doi: 10.1120/jacmp.v16i6.5810.
2
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.容积调强弧形治疗:前列腺癌病例的计划和评估。
Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1456-62. doi: 10.1016/j.ijrobp.2009.03.033. Epub 2009 Jun 18.
3
Dosimetric effect of body contour changes for prostate and head and neck volumetric modulated arc therapy plans.身体轮廓变化对前列腺及头颈部容积调强弧形放疗计划的剂量学影响。
J Appl Clin Med Phys. 2019 Apr;20(4):115-124. doi: 10.1002/acm2.12571. Epub 2019 Mar 29.
4
Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.使用三维剂量测定系统分析容积调强弧形放疗中多叶准直器位置误差的直接临床后果。
J Appl Clin Med Phys. 2015 Sep 8;16(5):296–305. doi: 10.1120/jacmp.v16i5.5515.
5
Dosimetric comparison of head and neck cancer patients planned with multivendor volumetric modulated arc therapy technology.使用多厂商容积调强弧形治疗技术进行计划的头颈癌患者的剂量学比较。
J Cancer Res Ther. 2017 Jan-Mar;13(1):122-130. doi: 10.4103/0973-1482.203600.
6
Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.基于等角度间隔均匀强度放射的鼻咽癌容积调强弧形治疗中的剂量-体积直方图预测。
Phys Med Biol. 2019 Dec 5;64(23):23NT03. doi: 10.1088/1361-6560/ab5433.
7
Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.评估容积旋转调强放疗(VMAT)相对于调强放疗(IMRT)和螺旋断层放疗(Tomo)在局限性、局部晚期和术后前列腺癌治疗中的作用。
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1550-8. doi: 10.1016/j.ijrobp.2010.10.024. Epub 2011 May 3.
8
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.评估使用同步整合加量的容积调强弧形放疗(SIB-VMAT)的可行性:针对复杂头颈癌、高危前列腺癌和直肠癌病例的分析。
Med Dosim. 2014 Spring;39(1):108-16. doi: 10.1016/j.meddos.2013.11.001. Epub 2013 Dec 15.
9
A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.两种盆腔淋巴结勾画技术的治疗计划和急性毒性比较以及调强放疗与容积旋转调强放疗在高危前列腺癌放射治疗中的分次剂量比较。
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e657-62. doi: 10.1016/j.ijrobp.2011.09.006. Epub 2012 Jan 13.
10
Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.左侧早期乳腺癌的混合容积调强弧形放疗、容积调强弧形放疗和调强放射治疗的剂量学比较
Med Dosim. 2015 Autumn;40(3):262-7. doi: 10.1016/j.meddos.2015.05.003. Epub 2015 Jun 23.

引用本文的文献

1
Effect of body contour changes on the setup and dosimetric accuracy of radiotherapy after cervical cancer surgery.宫颈癌手术后身体轮廓变化对放射治疗摆位及剂量准确性的影响。
Front Oncol. 2024 Sep 2;14:1392741. doi: 10.3389/fonc.2024.1392741. eCollection 2024.
2
Statistical process control to monitor use of a web-based autoplanning tool.利用基于网络的自动规划工具进行统计过程控制监测。
J Appl Clin Med Phys. 2022 Dec;23(12):e13803. doi: 10.1002/acm2.13803. Epub 2022 Oct 27.

本文引用的文献

1
Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.前列腺和头颈部病例单弧容积调强放疗中生物优化与物理优化的效率比较
J Appl Clin Med Phys. 2014 Jul 8;15(4):4514. doi: 10.1120/jacmp.v15i4.4514.
2
Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer.Acuros XB、AAA和XVMC在肺癌立体定向体部放射治疗中的剂量学比较。
Med Phys. 2014 Aug;41(8):081715. doi: 10.1118/1.4890592.
3
Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176.
治疗床面和固定装置引起的剂量学效应:美国医学物理师协会任务组176报告
Med Phys. 2014 Jun;41(6):061501. doi: 10.1118/1.4876299.
4
Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans.用于立体定向和传统肺容积调强弧形放疗计划的Acuros XB和AAA剂量计算算法的剂量学准确性和临床质量。
Radiat Oncol. 2013 Jun 24;8:149. doi: 10.1186/1748-717X-8-149.
5
Clinical experience transitioning from IMRT to VMAT for head and neck cancer.头颈部癌从调强放射治疗(IMRT)过渡到容积旋转调强放疗(VMAT)的临床经验
Med Dosim. 2013 Summer;38(2):171-5. doi: 10.1016/j.meddos.2012.10.009. Epub 2012 Dec 14.
6
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors.使用塑料闪烁探测器对前列腺调强放射治疗(IMRT)和容积调强弧形放疗(VMAT)进行模体剂量验证。
Radiat Meas. 2012 Oct 1;47(10):921-929. doi: 10.1016/j.radmeas.2012.08.005. Epub 2012 Aug 24.
7
Clinical application of RapidArc volumetric modulated arc therapy as a component in whole brain radiation therapy for poor prognostic, four or more multiple brain metastases.容积弧形调强放疗(RapidArc)作为预后不良的4个或更多多发脑转移瘤全脑放疗组成部分的临床应用
Radiat Oncol J. 2012 Jun;30(2):53-61. doi: 10.3857/roj.2012.30.2.53. Epub 2012 Jun 30.
8
RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.RapidArc 与调强放疗治疗肝细胞癌的比较计划研究。
Br J Radiol. 2012 Jul;85(1015):e323-9. doi: 10.1259/bjr/19088580.
9
Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy.随机Ⅱ期临床试验:保留尿道的低危前列腺癌调强放疗——对局限性治疗的影响。
Radiat Oncol. 2012 Jun 9;7:82. doi: 10.1186/1748-717X-7-82.
10
Accuracy of Acuros XB and AAA dose calculation for small fields with reference to RapidArc(®) stereotactic treatments.Acuros XB 和 AAA 剂量计算在 RapidArc(®)立体定向治疗中小野的准确性。
Med Phys. 2011 Nov;38(11):6228-37. doi: 10.1118/1.3654739.